Physician
Great Lakes Medical Associates, PC
Great Lakes Medical Associates, PC was paid $2.04M by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 59% of everything it billed.
33Billing provider infoGREAT LAKES MEDICAL ASSOCIATES, PC
EDMORE, MI 48829
EDMORE, MI 48829
33aNPI1811094295assigned 09/20/2006
33bProvider typeFamily Medicine Physician
28Total paid$2.04M
24GClaims45,470
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Michigan
Rank by total paid#62 of 826
Median peer was paid$98K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,815 | $191K | |
| 2019 | 6,059 | $233K | |
| 2020 | 6,854 | $257K | |
| 2021 | 8,268 | $379K | |
| 2022 | 7,583 | $358K | |
| 2023 | 6,040 | $323K | |
| 2024incomplete | 4,851 | $300K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 59% | 16,540 | 14,437 | $1.20M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 5,653 | 5,030 | $290K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.1% | 1,449 | 1,338 | $145K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 4.0% | 881 | 868 | $81K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.9% | 694 | 689 | $60K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.0% | 380 | 365 | $41K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 1.5% | 621 | 592 | $30K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 3,135 | 2,576 | $25K |
| 99406 | 1.1% | 3,229 | 2,912 | $23K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 247 | 244 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 420 | 390 | $17K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,464 | 1,431 | $14K |
47 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 102 | $9K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,258 | $8K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 83 | $7K |
| 90686 | <1% | 692 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,118 | $7K |
| 96127 | <1% | 1,729 | $6K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 257 | $5K |
| 96160 | <1% | 417 | $5K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 53 | $5K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 122 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 281 | $4K |
| 99457 | <1% | 218 | $3K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 28 | $2K |
| 0011A | <1% | 67 | $2K | |
| 0012A | <1% | 56 | $2K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 29 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 144 | $2K |
| 99454 | <1% | 140 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 291 | $1K |
| 81002 | <1% | 551 | $1K | |
| 99442 | <1% | 46 | $847.72 | |
| 20610 | <1% | 26 | $766.58 | |
| 93000 | <1% | 81 | $590.57 | |
| 98968 | <1% | 67 | $571.11 | |
| 99000 | <1% | 66 | $514.17 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 30 | $491.12 |
| 99441 | <1% | 58 | $449.53 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 117 | $444.80 |
| 99401 | <1% | 20 | $363.54 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 29 | $357.83 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 282 | $337.03 |
| 94060 | <1% | 13 | $299.38 | |
| 98966 | <1% | 73 | $262.79 | |
| 98967 | <1% | 60 | $250.33 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 65 | $230.99 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 152 | $193.26 |
| 81000 | <1% | 67 | $183.23 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 100 | $180.55 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 134 | $148.04 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 39 | $64.06 |
| 4010F | <1% | 90 | $0.11 | |
| 3074F | <1% | 162 | $0.01 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 403 | $0.00 |
| 2028F | 0% | 316 | $0.00 | |
| 3078F | 0% | 118 | $0.00 | |
| 3044F | 0% | 414 | $0.00 | |
| 3061F | 0% | 93 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSARVEPALLI, PRAKASH (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Prism Medical Associates, PC | Alma, MI | $994K |
| Isabella Medical Associates, PLLC | Edmore, MI | $120K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.